Small study tests High-Dose antibiotic for sepsis

NCT ID NCT07245966

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how a high dose of the antibiotic ceftriaxone works in 20 adults with sepsis. Researchers measured drug levels in the blood to see if the dose was strong enough to kill bacteria. The goal was to find the best dose to improve survival in sepsis patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ceftriaxone (a broad-spectrum antibiotic)

What this could lead to

If successful, this could help doctors choose the right dose of ceftriaxone for sepsis patients, potentially improving survival.

What could go wrong

This was a very small study (20 people) that only measured drug levels, not patient outcomes. The results may not apply to all sepsis patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Medicine, Prince of Songkla University

    Hat Yai, Changwat Songkhla, 90110, Thailand